Your browser doesn't support javascript.
loading
PPA2-associated sudden cardiac death: extending the clinical and allelic spectrum in 20 new families.
Guimier, Anne; Achleitner, Melanie T; Moreau de Bellaing, Anne; Edwards, Matthew; de Pontual, Loïc; Mittal, Kirti; Dunn, Kyla E; Grove, Megan E; Tysoe, Carolyn J; Dimartino, Clémantine; Cameron, Jessie; Kanthi, Anil; Shukla, Anju; van den Broek, Florence; Chatterjee, Diptendu; Alston, Charlotte L; Knowles, Charlotte V; Brett, Laura; Till, Jan A; Homfray, Tessa; French, Paul; Spentzou, Georgia; Elserafy, Noha A; Lichkus, Kate S; Sankaran, Bindu P; Kennedy, Hannah L; George, Peter M; Kidd, Alexa; Wortmann, Saskia B; Fisk, Dianna G; Koopmann, Tamara T; Rafiq, Muhammad A; Merker, Jason D; Parikh, Sumith; Ahimaz, Priyanka; Weintraub, Robert G; Ma, Alan S; Turner, Christian; Ellaway, Carolyn J; Phillips, Liza K; Thorburn, David R; Chung, Wendy K; Kana, Sajel L; Faye-Petersen, Ona M; Thompson, Michelle L; Janin, Alexandre; McLeod, Karen; McGowan, Ruth; McFarland, Robert; Girisha, Katta M.
Afiliação
  • Guimier A; INSERM U1163, Université de Paris, Institut Imagine, Paris, France.
  • Achleitner MT; Service de Génétique, Hôpital Necker Enfants Malades, APHP, Paris, France.
  • Moreau de Bellaing A; Department of Pediatrics, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Edwards M; INSERM U1163, Université de Paris, Institut Imagine, Paris, France.
  • de Pontual L; Unité médico-chirurgicale de cardiologie pédiatrique, Hôpital Necker Enfants Malades, APHP, Paris, France.
  • Mittal K; Clinical Genetics and Genomics Laboratory, Royal Brompton and Harefield NHS Trust, London, UK.
  • Dunn KE; INSERM U1163, Université de Paris, Institut Imagine, Paris, France.
  • Grove ME; Translational Medicine program and the Genetics & Genome Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Canada.
  • Tysoe CJ; Children's Heart Center, Stanford Children's Health, Palo Alto, CA, USA.
  • Dimartino C; Stanford Medicine Clinical Genomics Program, Stanford, CA, USA.
  • Cameron J; Exeter Genomics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
  • Kanthi A; INSERM U1163, Université de Paris, Institut Imagine, Paris, France.
  • Shukla A; Translational Medicine program and the Genetics & Genome Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Canada.
  • van den Broek F; Department of Medical Genetics, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India.
  • Chatterjee D; Department of Medical Genetics, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India.
  • Alston CL; Department of Pediatrics, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Knowles CV; Translational Medicine program and the Genetics & Genome Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Canada.
  • Brett L; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Till JA; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Homfray T; Clinical Genetics and Genomics Laboratory, Royal Brompton and Harefield NHS Trust, London, UK.
  • French P; Paediatric Cardiology, Royal Brompton and Harefield NHS Trust, London, UK.
  • Spentzou G; Clinical Genetics and Genomics Laboratory, Royal Brompton and Harefield NHS Trust, London, UK.
  • Elserafy NA; West of Scotland Centre for Genomic Medicine, Queen Elizabeth University Hospital, Glasgow, UK.
  • Lichkus KS; The Royal Hospital for Children, Glasgow, UK.
  • Sankaran BP; Department of Pediatrics, Columbia University, New York, NY, USA.
  • Kennedy HL; Genetic Metabolic Disorders Service, The Children's Hospital at Westmead, Sydney Children's Hospital Network, Sydney, NSW, Australia.
  • George PM; Genetic Metabolic Disorders Service, The Children's Hospital at Westmead, Sydney Children's Hospital Network, Sydney, NSW, Australia.
  • Kidd A; Genetic Metabolic Disorders Service, The Children's Hospital at Westmead, Sydney Children's Hospital Network, Sydney, NSW, Australia.
  • Wortmann SB; Department of Psychological Medicine, University of Otago, Christchurch, New Zealand.
  • Fisk DG; Pathogene, Christchurch, New Zealand.
  • Koopmann TT; Clinical Genetics New Zealand, Christchurch, New Zealand.
  • Rafiq MA; Department of Pediatrics, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Merker JD; Amalia Children's Hospital, Radboudumc, Nijmegen, The Netherlands.
  • Parikh S; Stanford Medicine Clinical Genomics Program, Stanford, CA, USA.
  • Ahimaz P; Translational Medicine program and the Genetics & Genome Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Canada.
  • Weintraub RG; Translational Medicine program and the Genetics & Genome Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Canada.
  • Ma AS; Department of Pathology, School of Medicine, Stanford, CA, USA.
  • Turner C; Departments of Pathology and Laboratory Medicine & Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina School Medicine, Chapel Hill, NC, USA.
  • Ellaway CJ; Mitochondrial Medicine Center, Neuroscience Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Phillips LK; Department of Pediatrics, Columbia University, New York, NY, USA.
  • Thorburn DR; The Royal Children's Hospital Melbourne, Melbourne, VIC, Australia.
  • Chung WK; Department of Clinical Genetics, Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, Australia.
  • Kana SL; Disciplines of Genomic Medicine and Child and Adolescent Health, University of Sydney, Sydney, Australia.
  • Faye-Petersen OM; Heart Centre for Children, The Children's Hospital at Westmead, Sydney, Australia.
  • Thompson ML; Genetic Metabolic Disorders Service, The Children's Hospital at Westmead, Sydney Children's Hospital Network, Sydney, NSW, Australia.
  • Janin A; Disciplines of Genomic Medicine and Child and Adolescent Health, University of Sydney, Sydney, Australia.
  • McLeod K; SA Pathology, Department of Genetics and Molecular Pathology, Adelaide, SA, Australia.
  • McGowan R; University of Adelaide, Adelaide, SA, Australia.
  • McFarland R; Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, Australia.
  • Girisha KM; Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.
Genet Med ; 23(12): 2415-2425, 2021 12.
Article em En | MEDLINE | ID: mdl-34400813
ABSTRACT

PURPOSE:

Biallelic hypomorphic variants in PPA2, encoding the mitochondrial inorganic pyrophosphatase 2 protein, have been recently identified in individuals presenting with sudden cardiac death, occasionally triggered by alcohol intake or a viral infection. Here we report 20 new families harboring PPA2 variants.

METHODS:

Synthesis of clinical and molecular data concerning 34 individuals harboring five previously reported PPA2 variants and 12 novel variants, 11 of which were functionally characterized.

RESULTS:

Among the 34 individuals, only 6 remain alive. Twenty-three died before the age of 2 years while five died between 14 and 16 years. Within these 28 cases, 15 died of sudden cardiac arrest and 13 of acute heart failure. One case was diagnosed prenatally with cardiomyopathy. Four teenagers drank alcohol before sudden cardiac arrest. Progressive neurological signs were observed in 2/6 surviving individuals. For 11 variants, recombinant PPA2 enzyme activities were significantly decreased and sensitive to temperature, compared to wild-type PPA2 enzyme activity.

CONCLUSION:

We expand the clinical and mutational spectrum associated with PPA2 dysfunction. Heart failure and sudden cardiac arrest occur at various ages with inter- and intrafamilial phenotypic variability, and presentation can include progressive neurological disease. Alcohol intake can trigger cardiac arrest and should be strictly avoided.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Morte Súbita Cardíaca / Cardiomiopatias Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adolescent / Child, preschool / Humans Idioma: En Revista: Genet Med Assunto da revista: GENETICA MEDICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Morte Súbita Cardíaca / Cardiomiopatias Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adolescent / Child, preschool / Humans Idioma: En Revista: Genet Med Assunto da revista: GENETICA MEDICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França